Hindson Benjamin J. 4
4 · 10x Genomics, Inc. · Filed Aug 3, 2023
Insider Transaction Report
Form 4
Hindson Benjamin J.
DirectorSee Remarks
Transactions
- Sale
Class A Common Stock
2023-08-01$62.36/sh−5,243$326,933→ 284,236 total - Exercise/Conversion
Stock Option (right to buy)
2023-08-01−6,970→ 23,312 totalExercise: $11.48Exp: 2029-05-10→ Class A Common Stock (6,970 underlying) - Exercise/Conversion
Class A Common Stock
2023-08-01$11.48/sh+6,970$80,016→ 291,206 total - Sale
Class A Common Stock
2023-08-01$61.77/sh−1,727$106,679→ 289,479 total
Footnotes (4)
- [F1]The transaction reported herein was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 13, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $61.12 to $62.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F3]This transaction was executed in multiple trades at prices ranging from $62.12 to $62.70. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.